Tang Chun Wai Nelson
Nan Fung Group Holdings Ltd
Assets Managed
$121.265M
Holdings
24
Last Quarter
2026 - Q1
Filed Date
9d ago
Growth Rate
8.54%(2Q avg: 47.98%)
Sustained Growth
2 quarters
Portfolio positions
This chart displays the top 10 holdings in Nan Fung Group Holdings Ltd's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 24 positions.
Assets under management
The assets under management (AUM) of Nan Fung Group Holdings Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 121.265M in assets, with a quarterly growth rate of 8.54% and a 2-quarter average growth rate of 47.98%. The portfolio is managed by Tang Chun Wai Nelson, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
EVMN Evommune Inc
| 27.32% | $33.129M 1.441M shares@ $23.0 avg price | |
MPLT Maplight Therapeutics Inc
| 16.29% | $19.746M 971,253 shares@ $20.33 avg price | |
LBRX Lb Pharmaceuticals Inc
| 12.83% | $15.552M 630,657 shares@ $24.67 avg price | Increased 110.22% |
OCS Oculis Holding Ag
| 7.7% | $9.326M 350,745 shares@ $26.6 avg price | Decreased -31.85% |
INCY Incyte Corp
| 4.18% | $5.058M 53,742 shares@ $94.12 avg price | Decreased -8.94% |
BGNE Beigene Ltd-adr
| 3.86% | $4.669M 15,722 shares@ $296.97 avg price | |
RYTM Rhythm Pharmaceuticals Inc
| 3.53% | $4.272M 49,120 shares@ $86.97 avg price | |
CELC Celcuity Inc
| 2.67% | $3.23M 28,300 shares@ $114.14 avg price | New Position |
ASND Ascendis Pharma A S - Adr
| 2.57% | $3.111M 13,600 shares@ $228.73 avg price | |
PCOR Procore Technologies Inc
| 2.51% | $3.038M 53,299 shares@ $57.0 avg price |
1-10 of 24